scholarly journals Regulation of Insurance with Adverse Selection and Switching Costs: Evidence from Medicare Part D.

2015 ◽  
Author(s):  
Maria Polyakova
2016 ◽  
Vol 8 (3) ◽  
pp. 165-195 ◽  
Author(s):  
Maria Polyakova

I take advantage of regulatory and pricing dynamics in Medicare Part D to explore interactions among adverse selection, inertia, and regulation. I first document novel evidence of adverse selection and switching frictions within Part D using detailed administrative data. I then estimate a contract choice and pricing model that quantifies the importance of inertia for risk sorting. I find that in Part D switching costs help sustain an adversely-selected equilibrium. I also estimate that active decision making in the existing policy environment could lead to a substantial gain in annual consumer surplus of on average $400–$600 per capita—20 percent to 30 percent of average annual spending. (JEL D82, G22, H51, I13, I18)


2021 ◽  
Vol 111 (9) ◽  
pp. 2737-2781
Author(s):  
Florian Heiss ◽  
Daniel McFadden ◽  
Joachim Winter ◽  
Amelie Wuppermann ◽  
Bo Zhou

Consumers’ health plan choices are highly persistent even though optimal plans change over time. This paper separates two sources of inertia, inattention to plan choice and switching costs. We develop a panel data model with separate attention and choice stages, linked by heterogeneity in acuity, i.e., the ability and willingness to make diligent choices. Using data from Medicare Part D, we find that inattention is an important source of inertia but switching costs also play a role, particularly for low-acuity individuals. Separating the two stages and allowing for heterogeneity is crucial for counterfactual simulations of interventions that reduce inertia. (JEL D12, G22, H51, I13, I18, L65)


2011 ◽  
Vol 101 (3) ◽  
pp. 382-386 ◽  
Author(s):  
Dana P Goldman ◽  
Geoffrey F Joyce ◽  
William B Vogt

Medicare Part D relies upon drug plan competition. Plans have enormous scope to design benefits and to set premiums, but they may not charge differential premiums based on risk. We use the formulary and benefit design of all Medicare prescription drug plans and pharmacy claims data to construct a simulation model of out-of-pocket drug spending. We use this simulation model to examine individual incentives in Medicare Part D for adverse selection. We find that high drug users have much stronger incentives to enroll in generous plans than do low users, thus there is significant scope for adverse selection.


2014 ◽  
Vol 10 (2) ◽  
pp. 398-407 ◽  
Author(s):  
Jayoung Han ◽  
Dong Woo Ko ◽  
Julie M. Urmie

2018 ◽  
Vol 10 (3) ◽  
pp. 154-192 ◽  
Author(s):  
Kurt Lavetti ◽  
Kosali Simon

The design of Medicare Part D causes most beneficiaries to receive fragmented health insurance, with drug and medical coverage separated. Fragmentation is potentially inefficient since separate insurers optimize over only one component of healthcare spending, despite complementarities and substitutabilities between healthcare types. Fragmentation of only some plans can also lead to market distortions due to differential adverse selection, as integrated plans may use drug formularies to induce enrollment by patients that are profitable in the medical insurance market. We study the design of insurance plans in Medicare Part D and find that formularies reflect these two differences in incentives. (JEL D82, G22, H51, I13, I18, L65)


2016 ◽  
Author(s):  
Florian Heiss ◽  
Daniel McFadden ◽  
Joachim Winter ◽  
Amelie Wuppermann ◽  
Bo Zhou

2006 ◽  
Vol 39 (4) ◽  
pp. 1-10
Author(s):  
MARY ELLEN SCHNEIDER

Sign in / Sign up

Export Citation Format

Share Document